Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Efficacy and Safety of Subcutaneous Self-administered Gefurulimab in Generalized Myasthenia Gravis: Primary Results From the Phase Three, Randomized, Double-blind, Placebo-controlled PREVAIL Study

Top-line Results From MaGic, a Phase Two Trial of Claseprubart (DNTH103), an Active C1s Inhibitor, in Generalized Myasthenia Gravis

Efficacy and Safety of Efgartigimod in Anti-acetylcholine Receptor Antibody–Negative Generalized Myasthenia Gravis: Initial Results of ADAPT SERON

Rapid and Sustained Efficacy of Subcutaneously Administered Cemdisiran Without Complete Complement Blockade in Patients with Generalized Myasthenia Gravis (gMG): Primary Efficacy and Safety Results from the Phase Three NIMBLE Trial

Functional Improvement in Patients With Myasthenia Gravis Following GLP-1/GIP Receptor Agonist Therapy: A Case Series